Specific asymmetric behavior induced by the direct chemical stimulation of neostriatal dopaminergic mechanisms.
D000818:Animals; D001522:Behavior, Animal / Q000187:drug effects*; D001921:Brain / Q000033:anatomy & histology; D002421:Caudate Nucleus; D002540:Cerebral Cortex; D003342:Corpus Striatum / Q000187:drug effects*; D004298:Dopamine / Q000494:pharmacology / Q000502:physiology*; D004357:Drug Synergism; D005917:Globus Pallidus; D006220:Haloperidol / Q000494:pharmacology; D007267:Injections / Q000379:methods; D008297:Male; D008996:Monoamine Oxidase Inhibitors / Q000494:pharmacology; D009043:Motor Activity / Q000187:drug effects; D009526:Nialamide / Q000494:pharmacology; D011699:Putamen; D051381:Rats; D013238:Stereotaxic Techniques; D013268:Stimulation, Chemical; D013378:Substantia Nigra / Q000502:physiology; D013788:Thalamus
D008996:Monoamine Oxidase Inhibitors; D006220:Haloperidol; D009526:Nialamide; D004298:Dopamine